Cardiovascular changes in animal models of metabolic syndrome

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Lehnen, Alexandre M ^a,b   Rodrigues, Bruno ^c   Irigoyen, Maria Cláudia ^d   De Angelis, Kátia ^e   Schaan, Beatriz D'Agord ^b  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUTAMATE SODIUM; SUCROSE;

ANIMAL MODEL; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; DIABETIC HYPERTENSION; GENETIC MODEL; HUMAN; LIPID DIET; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT STRAIN; REVIEW; STREPTOZOCIN DIABETES;

EID: 84879375034     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/761314     Document Type: Review

References (112)

1. Alberti K. G. M. M., Zimmet P., Shaw J., Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine 2006 23 5 469 480 2-s2.0-33645978121 10.1111/j.1464-5491.2006.01858.x
2. Defina L. F., Vega G. L., Leonard D., Grundy S. M., Fasting glucose, obesity, and metabolic syndrome as predictors of type 2 diabetes: the cooper center longitudinal study. Journal of Investigative Medicine 2012 60 8 1164 1168
3. Dekker J. M., Girman C., Rhodes T., Nijpels G., Stehouwer C. D. A., Bouter L. M., Heine R. J., Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005 112 5 666 673 2-s2.0-23244440374 10.1161/CIRCULATIONAHA.104.516948 (Pubitemid 41099045)
4. Mulè G., Nardi E., Cottone S., Cusimano P., Volpe V., Piazza G., Mongiovì R., Mezzatesta G., Andronico G., Cerasola G., Influence of metabolic syndrome on hypertension-related target organ damage. Journal of Internal Medicine 2005 257 6 503 513 2-s2.0-20144380553 10.1111/j.1365-2796. 2005.01493.x (Pubitemid 40776510)
5. de las Fuentes L., Brown A. L., Mathews S. J., Waggoner A. D., Soto P. F., Gropler R. J., Dávila-Román V. G., Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. European Heart Journal 2007 28 5 553 559 2-s2.0-34250866507 10.1093/eurheartj/ehl526 (Pubitemid 47355514)
6. Pyörälä M., Miettinen H., Halonen P., Laakso M., Pyörälä K., Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2 538 544 2-s2.0-0343485089 (Pubitemid 30086114)
7. Choi K. M., Ryu O. H., Lee K. W., Kim H. Y., Seo J. A., Kim S. G., Kim N. H., Choi D. S., Baik S. H., Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Research and Clinical Practice 2007 75 2 235 240 2-s2.0-33845447909 10.1016/j.diabres.2006.06.019 (Pubitemid 44894605)
8. Emanuela F., Grazia M., Marco D. R., Maria Paola L., Giorgio F., Marco B., Inflammation as a link between obesity and metabolic syndrome. Journal of Nutrition and Metabolism 2012 2012 7 476380 10.1155/2012/476380
9. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., More K. J., Breitbart R. E., Duyk G. M., Tepper R. I., Morgenstern J. P., Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996 84 3 491 495 2-s2.0-13344259300 10.1016/S0092-8674(00)81294-5 (Pubitemid 26060722)
10. Kanie N., Kamata K., Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice. General Pharmacology 2000 35 6 311 318 2-s2.0-1842853749 10.1016/S0306-3623(02)00115-5 (Pubitemid 34258513)
11. Senador D., Kanakamedala K., Irigoyen M. C., Morris M., Elased K. M., Cardiovascular and autonomic phenotype of db/db diabetic mice. Experimental Physiology 2009 94 6 648 658 2-s2.0-65649109348 10.1113/expphysiol.2008.046474
12. Tessari F., Travagli R. A., Zanoni R., Prosdocimi M., Effects of long-term diabetes and treatment with gangliosides on cardiac sympathetic innervation: a biochemical and functional study in mice. Journal of Diabetic Complications 1988 2 1 34 37 2-s2.0-0023803907
13. Semeniuk L. M., Kryski A. J., Severson D. L., Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. American Journal of Physiology 2002 283 3 H976 H982 2-s2.0-0036353834
14. Daniels A., van Bilsen M., Janssen B. J. A., Brouns A. E., Cleutjens J. P. M., Roemen T. H. M., Schaart G., van der Velden J., van der Vusse G. J., van Nieuwenhoven F. A., Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling. Acta Physiologica 2010 200 1 11 22 2-s2.0-77955139510 10.1111/j.1748-1716.2010.02102. x
15. Iwatsuka H., Shino A., Suzuoki Z., General survey of diabetic features of yellow KK mice. Endocrinologia Japonica 1970 17 1 23 35 2-s2.0-0014743725
16. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., Matsuoka N., Hayashi T., Hosoda K., Inoue G., Yoshimasa Y., Nakao K., Pathophysiological role of leptin in obesity-related hypertension. The Journal of Clinical Investigation 2000 105 9 1243 1252 2-s2.0-12944257370 (Pubitemid 30266077)
17. Ohashi K., Kihara S., Ouchi N., Kumada M., Fujita K., Hiuge A., Hibuse T., Ryo M., Nishizawa H., Maeda N., Maeda K., Shibata R., Walsh K., Funahashi T., Shimomura I., Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006 47 6 1108 1116 2-s2.0-33744979305 10.1161/01.HYP.0000222368.43759.a1 (Pubitemid 44289168)
18. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 2-s2.0-0028139089 10.1038/372425a0 (Pubitemid 24365442)
19. Mark A. L., Shaffer R. A., Correia M. L. G., Morgan D. A., Sigmund C. D., Haynes W. G., Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. Journal of Hypertension 1999 17 12, part 2 1949 1953 2-s2.0-0033512117 (Pubitemid 30345336)
20. Young J. B., Landsberg L., Diminished sympathetic nervous system activity in genetically obese (ob/ob) mouse. American Journal of Physiology 1983 245 2 E148 E154 2-s2.0-0020808307 (Pubitemid 13031383)
21. Swoap S. J., Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction. American Journal of Physiology 2001 281 6 H2473 H2479 2-s2.0-0035665513
22. Dobrzyn P., Dobrzyn A., Miyazaki M., Ntambi J. M., Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. Journal of Lipid Research 2010 51 8 2202 2210 2-s2.0-77956822412 10.1194/jlr.M003780
23. Zaman A. K. M. T., Fujii S., Goto D., Furumoto T., Mishima T., Nakai Y., Dong J., Imagawa S., Sobel B. E., Kitabatake A., Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. Journal of Molecular and Cellular Cardiology 2004 37 2 525 535 2-s2.0-3242694239 10.1016/j.yjmcc.2004.05.006 (Pubitemid 38953380)
24. Ae Park S., Choi M. S., Cho S. Y., Seo J. S., Jung U. J., Kim M. J., Sung M. K., Park Y. B., Lee M. K., Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sciences 2006 79 12 1207 1213 2-s2.0-33746591715 10.1016/j.lfs.2006.03.022 (Pubitemid 44144498)
25. Dong Y. F., Liu L., Kataoka K., Nakamura T., Fukuda M., Tokutomi Y., Nako H., Ogawa H., Kim-Mitsuyama S., Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia 2010 53 1 180 191 2-s2.0-72449207970 10.1007/s00125-009-1575-5
26. u haplotype) rat. Metabolism 2000 49 9 1140 1144 2-s2.0-0033811405 10.1053/meta.2000.8610
27. van den Brandt J., Kovacs P., Kloting I., Metabolic features in disease-resistant as well as in spontaneously hypertensive rats and newly established obese Wistar Ottawa Karlsburg inbred rats. International Journal of Obesity 2000 24 12 1618 1622 2-s2.0-0033647404
28. Kondo H., Shimomura L., Matsukawa Y., Kumada M., Takahashi M., Matsuda M., Ouchi N., Kihara S., Kawamoto T., Sumitsuji S., Funahashi T., Matsuzawa Y., Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002 51 7 2325 2328 2-s2.0-0036303146 (Pubitemid 34729044)
29. Grisk O., Frauendorf T., Schlüter T., Klöting I., Kuttler B., Krebs A., Lüdemann J., Rettig R., Impaired coronary function in Wistar Ottawa Karlsburg W rats-a new model of the metabolic syndrome. Pflügers Archiv 2007 454 6 1011 1021 2-s2.0-34548313696 10.1007/s00424-007-0267-6 (Pubitemid 47338464)
30. Davis L. M., Michaelides M., Cheskin L. J., Moran T. H., Aja S., Watkins P. A., Pei Z., Contoreggi C., McCullough K., Hope B., Wang G. J., Volkow N. D., Thanos P. K., Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 2009 89 2 152 162 2-s2.0-61749089080 10.1159/000170586
31. Zucker L. M., Antoniades H. N., Insulin and obesity in the Zucker genetically obese rat 'fatty'. Endocrinology 1972 90 5 1320 1330 2-s2.0-0015336896
32. Schreihofer A. M., Mandel D. A., Mobley S. C., Stepp D. W., Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. American Journal of Physiology 2007 293 4 H2543 H2549 2-s2.0-35349001645 10.1152/ajpheart.01201.2006 (Pubitemid 47605902)
33. Zhou X., Ma L., Habibi J., Whaley-Connell A., Hayden M. R., Tilmon R. D., Brown A. N., Kim J. A., Demarco V. G., Sowers J. R., Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension 2010 55 4 880 888 2-s2.0-77950466818 10.1161/HYPERTENSIONAHA.109.145136
34. Osmond J. M., Mintz J. D., Dalton B., Stepp D. W., Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension 2009 53 2 381 386 2-s2.0-59849117985 10.1161/HYPERTENSIONAHA.108.124149
35. Morgan D. A., Anderson E. A., Mark A. L., Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 1995 25 4, part 2 834 838 2-s2.0-0028899389
36. Overton J. M., Williams T. D., Chambers J. B., Rashotte M. E., Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats. American Journal of Physiology 2001 280 4 R1007 R1015 2-s2.0-0035008129
37. Bunag R. D., Barringer D. L., Obese Zucker rats, though still normotensive, already have impaired chronotropic baroreflexes. Clinical and Experimental Hypertension A 1988 10 1, supplement 1 257 262 2-s2.0-0024210340 (Pubitemid 19078421)
38. Barringer D. L., Bunag R. D., Uneven blunting of chronotropic baroreflexes in obese Zucker rats. American Journal of Physiology 1989 256 2, part 2 H417 H421 2-s2.0-0024535474
39. Marsh S. A., Powell P. C., Agarwal A., Dell'Italia L. J., Chatham J. C., Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis. American Journal of Physiology 2007 293 1 H292 H298 2-s2.0-34547132057 10.1152/ajpheart.01362.2006 (Pubitemid 47105084)
40. Baynes J., Murray D. B., Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats. Oxidative Medicine and Cellular Longevity 2009 2 5 328 334 2-s2.0-77953435480 10.4161/oxim.2.5.9831
41. van den Brom C. E., Huisman M. C., Vlasblom R., Boontje N. M., Duijst S., Lubberink M., Molthoff C. F. M., Lammertsma A. A., van der Velden J., Boer C., Ouwens D. M., Diamant M., Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovascular Diabetology 2009 8, article 39 2-s2.0-68949215755 10.1186/1475-2840-8-39
42. Oltman C. L., Davidson E. P., Coppey L. J., Kleinschmidt T. L., Yorek M. A., Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes, Obesity and Metabolism 2009 11 3 223 233 2-s2.0-59349098165 10.1111/j.1463-1326.2008.00924.x
43. Mizuno M., Sada T., Kato M., Fukushima Y., Terashima H., Koike H., The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes. Journal of Cardiovascular Pharmacology 2006 48 4 135 142 2-s2.0-33750605324 10.1097/01.fjc.0000245241.79959.d6 (Pubitemid 44691214)
44. Hattori T., Murase T., Ohtake M., Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat. Nutrition & Diabetes 2011 1 1 e1 e6 10.1038/nutd.2010.1
45. Murase T., Hattori T., Ohtake M., Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome. Hypertension Research 2012 35 2 186 193 10.1038/hr.2011.157
46. Moran T. H., Unraveling the obesity of OLETF rats. Physiology and Behavior 2008 94 1 71 78 2-s2.0-41849107486 10.1016/j.physbeh.2007.11.035 (Pubitemid 351503584)
47. Kawano K., Hirashima T., Mori S., Natori T., OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Research and Clinical Practice 1994 24, supplement S317 S320 2-s2.0-0028112936 10.1016/0168-8227(94) 90269-0
48. Sato T., Asahi Y., Toide K., Nakayama N., Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia 1995 38 9 1033 1041 2-s2.0-0029082892 10.1007/s001250050388
49. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., Matsuo H., Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000 101 8 899 907 2-s2.0-0034003574 (Pubitemid 30117886)
50. Yu Y., Ohmori K., Kondo I., Yao L., Noma T., Tsuji T., Mizushige K., Kohno M., Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. Cardiovascular Research 2002 56 2 303 311 2-s2.0-0036838546 10.1016/S0008- 6363(02)00513-8 (Pubitemid 35223501)
51. Saito F., Kawaguchi M., Izumida J., Asakura T., Maehara K., Maruyama Y., Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in OLETF rats. Diabetologia 2003 46 8 1161 1169 2-s2.0-0041877454 10.1007/s00125-003-1156-y (Pubitemid 37041247)
52. Goto Y., Kukizaki M., Masaki N., Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proceedings of the Japan Academy 1975 51 1 80 85
53. Gupte S., Labinskyy N., Gupte R., Csiszar A., Ungvari Z., Edwards J. G., Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM. PLoS ONE 2010 5 7 2-s2.0-77955640337 10.1371/journal.pone.0011800 e11800
54. Akiyama S., Katsumata S. I., Suzuki K., Nakaya Y., Ishimi Y., Uehara M., Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Bioscience, Biotechnology and Biochemistry 2009 73 12 2779 2782 2-s2.0-74349129815 10.1271/bbb.90576
55. D'Souza A., Howarth F. C., Yanni J., Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat. Experimental Physiology 2011 96 9 875 888
56. Howarth F. C., Shafiullah M., Qureshi M. A., Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat. Experimental Physiology 2007 92 6 1029 1036 2-s2.0-35248865704 10.1113/expphysiol.2007.038703 (Pubitemid 47568843)
57. Witte K., Reitenbach I., Stolpe K., Schilling L., Kirchengast M., Lemmer B., Effects of the endothelin a receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats. Journal of Cardiovascular Pharmacology 2003 41 6 890 896 2-s2.0-0038457616 10.1097/00005344-200306000-00009 (Pubitemid 36706136)
58. Konrad S. P., Farah V., Rodrigues B., Monosodium glutamate neonatal treatment induces cardiovascular autonomic function changes in rodents. Clinics 2012 67 10 1209 1214
59. Pfeffer J. M., Pfeffer M. A., Fishbein M. C., Frohlich E. D., Cardiac function and morphology with aging in the spontaneously hypertensive rat. American Journal of Physiology 1979 237 4 H461 468 2-s2.0-0018534189 (Pubitemid 10249649)
60. Doggrell S. A., Brown L., Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular Research 1998 39 1 89 105 2-s2.0-0032127809 10.1016/S0008-6363(98)00076-5 (Pubitemid 28322382)
61. Leguisamo N. M., Lehnen A. M., Machado U. F., GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovascular Diabetology 2012 11 1 100 10.1186/1475-2840-11-100
62. van den Buuse M., Versteeg D. H. G., de Jong W., Effects of neonatal treatment with monosodium-glutamate in spontaneously hypertensive rats. Brain Research 1985 351 1 135 138 (Pubitemid 15075744)
63. Lorden J. F., Caudle A., Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehavioral Toxicology and Teratology 1986 8 5 509 519 2-s2.0-0022853586 (Pubitemid 17221700)
64. Garruti G., Giampetruzzi F., Vita M. G., Links between metabolic syndrome and cardiovascular autonomic dysfunction. Experimental Diabetes Research 2012 2012 1 9 615835 10.1155/2012/615835
65. Grassi G., Arenare F., Quarti-Trevano F., Seravalle G., Mancia G., Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Progress in Cardiovascular Diseases 2009 52 1 31 37 2-s2.0-67650178028 10.1016/j.pcad.2009.05.007
66. Pollare T., Lithell H., Selinus I., Berne C., Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988 31 7 415 420 2-s2.0-0023759937
67. Jamerson K. A., Julius S., Gudbrandsson T., Andersson O., Brant D. O., Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993 21 5 618 623 2-s2.0-0027514229 (Pubitemid 23120215)
68. Snitker S., Macdonald I., Ravussin E., Astrup A., The sympathetic nervous system and obesity: role in aetiology and treatment. Obesity Reviews 2000 1 1 5 15 2-s2.0-0034179737
69. Sowers J. R., Nyby M., Stern N., Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982 4 5 686 691 2-s2.0-0020399813 (Pubitemid 13239687)
70. Junod A., Lambert A. E., Stauffacher W., Renold A. E., Diabetogenic action of streptozotocin: relationship of dose to metabolic response. The Journal of Clinical Investigation 1969 48 11 2129 2139 2-s2.0-0014606996
71. Tomlinson K. C., Gardiner S. M., Hebden R. A., Bennett T., Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacological Reviews 1992 44 1 103 150 2-s2.0-0026596711
72. Rodrigues B., Figueroa D. M., Mostarda C. T., Heeren M. V., Irigoyen M. C., de Angelis K., Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats. Cardiovascular Diabetology 2007 6 1, article 38 2-s2.0-38949124379 10.1186/1475-2840-6-38 (Pubitemid 351217925)
73. Wichi R., Malfitano C., Rosa K., de Souza S. B., Salemi V., Mostarda C., de Angelis K., Irigoyen M. C., Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovascular Diabetology 2007 6 1, article 14 2-s2.0-34248657965 10.1186/1475-2840-6-14 (Pubitemid 46772838)
74. Harthmann A. D., de Angelis K., Costa L. P., Senador D., Schaan B. D., Krieger E. M., Irigoyen M. C., Exercise training improves arterial baro- and chemoreflex in control and diabetic rats. Autonomic Neuroscience 2007 133 2 115 120 2-s2.0-34247181991 10.1016/j.autneu.2006.10.004 (Pubitemid 46613872)
75. Souza S. B. C., Flues K., Paulini J., Mostarda C., Rodrigues B., Souza L. E., Irigoyen M. C., de Angelis K., Role of exercise training in cardiovascular autonomic dysfunction and mortality in diabetic ovariectomized rats. Hypertension 2007 50 4 786 791 2-s2.0-34548832520 10.1161/HYPERTENSIONAHA.107. 095000 (Pubitemid 47442746)
76. Ménard S. L., Croteau E., Sarrhini O., Gélinas R., Brassard P., Ouellet R., Bentourkia M., van Lier J. E., Des Rosiers C., Lecomte R., Carpentier A. C., Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. American Journal of Physiology 2010 298 5 E1049 E1057 2-s2.0-77950798252 10.1152/ajpendo.00560.2009
77. Ferder L., Ferder M. D., Inserra F., The role of high-fructose corn syrup in metabolic syndrome and hypertension. Current Hypertension Reports 2010 12 2 105 112 2-s2.0-77953534278 10.1007/s11906-010-0097-3
78. Forshee R. A., Anderson P. A., Storey M. L., Sugar-sweetened beverages and body mass index in children and adolescents: a meta-analysis. American Journal of Clinical Nutrition 2008 87 6 1662 1671 2-s2.0-45749112463 (Pubitemid 351872628)
79. Martinez F. J., Rizza R. A., Romero J. C., High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension 1994 23 4 456 463 2-s2.0-0028210997 (Pubitemid 24102041)
80. Kamide K., Rakugi H., Higaki J., Okamura A., Nagai M., Moriguchi K., Ohishi M., Satoh N., Tuck M. L., Ogihara T., The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. American Journal of Hypertension 2002 15 1, part 1 66 71 2-s2.0-0036157841 10.1016/S0895-7061(01)02232-4 (Pubitemid 34102275)
81. Brito J. O., Ponciano K., Figueroa D., Bernardes N., Sanches I. C., Irigoyen M. C., de Angelis K., Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Brazilian Journal of Medical and Biological Research 2008 41 9 804 808 2-s2.0-54349088570
82. Cunha T. S., Farah V., Paulini J., Pazzine M., Elased K. M., Marcondes F. K., Cláudia Irigoyen M., de Angelis K., Mirkin L. D., Morris M., Relationship between renal and cardiovascular changes in a murine model of glucose intolerance. Regulatory Peptides 2007 139 1-3 1 4 2-s2.0-33846785566 10.1016/j.regpep.2006.11.023 (Pubitemid 46216490)
83. de Angelis K., Senador D. D., Mostarda C., Irigoyen M. C., Morris M., Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice. American Journal of Physiology 2012 302 8 R950 R957
84. Machi J. F., Bernardes N., Mostarda C., Walking promotes metabolic and baroreflex sensitivity improvement in fructose-fed male rats. European Journal of Applied Physiology 2012 113 1 41 49 10.1007/s00421-012-2411-z
85. Mostarda C., Moraes-Silva I. C., Salemi V. M., Exercise training prevents diastolic dysfunction induced by metabolic syndrome in rats. Clinics 2012 67 7 815 820 10.6061/clinics/2012(07)18
86. Sanches I. C., de Oliveira Brito J., Candido G. O., Cardiometabolic benefits of exercise training in an experimental model of metabolic syndrome and menopause. Menopause 2012 19 5 562 568
87. Farah V., Elased K. M., Chen Y., Key M. P., Cunha T. S., Irigoyen M. C., Morris M., Nocturnal hypertension in mice consuming a high fructose diet. Autonomic Neuroscience 2006 130 1-2 41 50 2-s2.0-33750967338 10.1016/j.autneu.2006.05.006 (Pubitemid 44750860)
88. Senador D., Shewale S., Irigoyen M. C., Elased K. M., Morris M., Effects of restricted fructose access on body weight and blood pressure circadian rhythms. Experimental Diabetes Research 2012 2012 7 459087 10.1155/2012/459087
89. Richey J. M., Ader M., Moore D., Bergman R. N., Angiotensin II induces insulin resistance independent of changes in interstitial insulin. American Journal of Physiology 1999 277 5, part 1 E920 E926 2-s2.0-0032760296
90. Giani J. F., Muñoz M. C., Mayer M. A., Veiras L. C., Arranz C., Taira C. A., Turyn D., Toblli J. E., Dominici F. P., Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats. American Journal of Physiology 2010 298 3 H1003 H1013 2-s2.0-77749291795 10.1152/ajpheart.00803.2009
91. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., Okamura T., Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004 43 2 255 262 2-s2.0-0842311015 10.1161/01.HYP.0000111136.86976.26 (Pubitemid 38174184)
92. Paul M., Poyan Mehr A., Kreutz R., Physiology of local renin-angiotensin systems. Physiological Reviews 2006 86 3 747 803 2-s2.0-33745845825 10.1152/physrev.00036.2005 (Pubitemid 44033382)
93. Xing S. S., Bi X. P., Tan H. W., Zhang Y., Xing Q. C., Zhang W., Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats. Molecular Medicine 2010 16 11-12 465 470 2-s2.0-78149244847 10.2119/molmed.2010.00028
94. Tappy L., Le K. A., Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews 2010 90 1 23 46 2-s2.0-75149166672 10.1152/physrev.00019.2009
95. Lombardo Y. B., Drago S., Chicco A., Fainstein-Day P., Gutman R., Gagliardino J. J., Gomez Dumm C. L., Long-term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas. Metabolism 1996 45 12 1527 1532 2-s2.0-0030447114 10.1016/S0026-0495(96)90183-3 (Pubitemid 26424582)
96. Vasanji Z., Cantor E. J. F., Juric D., Moyen M., Netticadan T., Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. American Journal of Physiology 2006 291 4 C772 C780 2-s2.0-33749370815 10.1152/ajpcell.00086.2005 (Pubitemid 44497602)
97. Bunag R. D., Tomita T., Sasaki S., Chronic sucrose ingestion induces mild hypertension and tachycardia in rats. Hypertension 1983 5 2 218 225 2-s2.0-0020664948 (Pubitemid 13164349)
98. Buettner R., Schölmerich J., Bollheimer L. C., High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007 15 4 798 808 2-s2.0-34248393099 10.1038/oby.2007.608 (Pubitemid 46740952)
99. Woods S. C., Seeley R. J., Rushing P. A., D'Alessio D., Tso P., A controlled high-fat diet induces an obese syndrome in rats. Journal of Nutrition 2003 133 4 1081 1087 2-s2.0-0037383261 (Pubitemid 36407129)
100. Prior L. J., Eikelis N., Armitage J. A., Davern P. J., Burke S. L., Montani J. P., Barzel B., Head G. A., Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010 55 4 862 868 2-s2.0-77950507182 10.1161/HYPERTENSIONAHA.109.141119
101. Fardin N. M., Oyama L. M., Campos R. R., Changes in baroreflex control of renal sympathetic nerve activity in high-fat-fed rats as a predictor of hypertension. Obesity 2012 20 8 1591 1597
102. Damjanovic M., Barton M., Fat intake and cardiovascular response. Current Hypertension Reports 2008 10 1 25 31 10.1007/s11906-008-0007-0 (Pubitemid 351255951)
103. Boustany C. M., Bharadwaj K., Daugherty A., Brown D. R., Randall D. C., Cassis L. A., Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. American Journal of Physiology 2004 287 4 R943 R949 2-s2.0-4644307190 10.1152/ajpregu.00265.2004 (Pubitemid 39280483)
104. Sampey B. P., Vanhoose A. M., Winfield H. M., Freemerman A. J., Muehlbauer M. J., Fueger P. T., Newgard C. B., Makowski L., Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity 2011 19 6 1109 1117 2-s2.0-79957482239 10.1038/oby.2011.18
105. Sclafani A., Springer D., Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiology and Behavior 1976 17 3 461 471 2-s2.0-0017182018 10.1016/0031-9384(76)90109-8
106. Heyne A., Kiesselbach C., Sahún I., McDonald J., Gaiffi M., Dierssen M., Wolffgramm J., An animal model of compulsive food-taking behaviour. Addiction Biology 2009 14 4 373 383 2-s2.0-70049101241 10.1111/j.1369-1600. 2009.00175.x
107. Morris M. J., Chen H., Watts R., Shulkes A., Cameron-Smith D., Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet. International Journal of Obesity 2008 32 2 249 258 2-s2.0-39449087112 10.1038/sj.ijo.0803716 (Pubitemid 351271782)
108. Muntzel M. S., Al-Naimi O. A., Barclay A., Ajasin D., Cafeteria diet increases fat mass and chronically elevates lumbar sympathetic nerve activity in rats. Hypertension 2012 60 6 1498 1502 10.1161/HYPERTENSIONAHA.112.194886
109. Haddock R. E., Grayson T. H., Morris M. J., Howitt L., Chadha P. S., Sandow S. L., Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS ONE 2011 6 1 2-s2.0-79251633164 10.1371/journal.pone.0016423 e16423
110. Miesel A., Muller H., Thermann M., Heidbreder M., Dominiak P., Raasch W., Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome. Annals of Nutrition and Metabolism 2010 56 2 127 142
111. Daffonchio A., Franzelli C., Di Rienzo M., Castiglioni P., Mancia G., Ferrari A. U., Sympathetic, parasympathetic and non-autonomic contributions to cardiovascular spectral powers in unanesthetized spontaneously hypertensive rats. Journal of Hypertension 1995 13 12, part 2 1636 1642 2-s2.0-0029609802 (Pubitemid 26015789)
112. Ju K., Kubo T., Power spectral analysis of autonomic nervous activity in spontaneously hypertensive rats. Biomedical Sciences Instrumentation 1997 33 1 338 343 2-s2.0-0031411530 (Pubitemid 28181507)